Nautilus Biotechnology

NAUTNasdaq United States Industrials Biotechnology: Laboratory Analytical Instruments

Market cap

$121.491 M

$0.95 -1.17%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$59.0M

Loss-making

Shares outstanding

127,255,223

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →

#13Standard BiotoolsLAB$291.3M
#14QuanterixQTRX$143.8M
#15Nautilus BiotechnologyNAUT$121.5M
#16SeerSEER$103.0M
#17Rapid Micro BiosystemsRPID$56.7M

What if Nautilus Biotechnology were worth as much as…

Open the what-if tool →

Gold $30.3T

$237,900.29

Per share 249,189× higher

Bitcoin $1.72T

$13,514.60

Per share 14,156× higher

Nvidia $5.48T

$43,061.95

Per share 45,105× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Nautilus Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.